奥洛他定联合聚乙二醇滴眼液治疗过敏性结膜炎的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Olopatadine combined with Polyethylene Glycol Eye Drops in the treatment of allergic conjunctivitis.Methods Atota of 120 patients (120 eyes) with allergic conjunctivitis who were treated in our hospital from January 2018 to June 2019 were selected, and divided into test group and control group by random number table method, with 60 cases (60 eyes) in each group.The control group was treated with Olopatadine Eye Drops.The test group was treated with Olopatadine and Polyethylene Glycol Eye Drops.The changes of clinical symptoms and signs, break up time (BUT), tear secretion test (Schimer Ⅰtest), corneal fluorescein staining, treatment effect and adverse reaction were compared between the two groups.Results There was no significant difference between the two groups in clinical symptoms and signs, BUT, schimer Ⅰtest and corneal fluorescein staining before treatment(P＞0.05).The symptom and sign scores and corneal fluorescein staining scores of the two groups after 2 weeks of treatment were lower than those before treatment, BUT and SchimerⅠtest were longer than those before treatment, and the differences were statistically significant (P＜0.05).The symptom and sign score and corneal fluorescein staining score of the test group were lower than those of the control group, BUT and SchimerⅠtest were longer than those of the control group, the differences were statistically significant (P＜0.05).The total effective rate of the test group was 91.7%, which was higher than that of control group (78.3%), and the difference was statistically significant (P＜0.05).All patients did not have adverse reactions during treatment, the original disease and ocular symptoms were not aggravated.Conclusion The clinical effect of Olopatadine combined with Polyethylene Glycol Eye Drops in the treatment of allergic conjunctivitis is significant, and with less adverse reactions, easy to operate.So it is a safe and effective treatment, which worth to promote the application in clinic.

Key words： Olopatadine Eye Grops Polyethylene Glycol Eye Drops Allergic conjunctivitis Therapeutic effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIU Xin-xin
	ZHAO Jian

Cite this article:

XIU Xin-xin,ZHAO Jian. Clinical effect of Olopatadine combined with Polyethylene Glycol Eye Drops in the treatment of allergic conjunctivitis[J]. 中国当代医药, 2020, 27(8): 127-130.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I8/127

[1]	刘红梅，钟凤如，熊雪蓉，等.舌下含服粉尘瞒滴剂治疗过敏性结膜炎的疗效与安全性评估[J].中华全科医师杂志，2014，13（8）：687-689.
[2]	沈剑.氯雷他定联合双氯芬酸钠滴眼液治疗过敏性结膜炎临床研究[J].国际眼科杂志2016，16（l）：157-159.
[3]	李艳艳，邝平.盐酸奥洛他定滴眼液联合普拉洛芬滴眼液治疗儿童变态反应性结膜炎的临床效果观察[J].中国当代医药，2014，21（18）：85-87.
[4]	庄耿刚，张丽君.奥洛他定治疗过敏性结膜炎的疗效及其对血清、泪液相关指标的影响[J].实用临床医药杂志，2016，20（5）：85-87.
[5]	赵春宁，秦宏，杨洪滨，等.奥洛他定联合玻璃酸钠滴眼液治疗过敏性结膜炎临床效果观察[J].中国医学前沿杂志（电子版），2016，8（8）：140-142.
[6]	刘院斌，武忠华，任志凤，等.奥洛他定联合双氯芬酸钠滴眼液治疗过敏性结膜炎观察[J].中国实用眼科杂志，2014，32（9）：1072-1075.
[7]	陆妍.普拉洛芬联合奥洛他定治疗过敏性结膜炎47例[J].中国民族民间医药杂志，2016，25（20）：95-96.
[8]	张廷艳.奥洛他定联合思然治疗过敏性结膜炎156例疗效观察[J].实用中西医结合临床，2014，14（5）：75-76.
[9]	姚娟，李冰，郑晓汾.不同类型过敏性结膜炎患者眼表组织白细胞介素-4、5和13的表达[J].中华实验眼科杂志，2015，33（10）：924-929.
[10]	朱敬敬，李兵.青篙素在小鼠花粉过敏性结膜炎早期反应相中的作用[J].国际眼科杂志，2016，16（6）：1032-1035.
[11]	张健，杨伊琳.应用奥洛他定滴眼液等药物联合治疗过敏性结膜炎疗效分析[J].国际眼科杂志，2017，17（2）：238-242.
[12]	杨海婷..地塞米松联合盐酸奥洛他定治疗过敏性结膜炎的临床效果[J].中国继续医学教育，2017，9（24）：165-166.
[13]	丁哲，谢立群.中西医结合治疗过敏性结膜炎的临床观察[J].中国中医急症，2 016，25（2）：229-231.
[14]	李瑶，丁汝新，陈雪艺.奥洛他定及双氯芬酸钠滴眼液联合治疗过敏性结膜炎88例[J].中国药业，2016，25（3）：116-118.
[15]	许婷.聚乙二醇滴眼液与玻璃酸钠滴眼液治疗干眼症的疗效对比[J].中国现代药物应用，2014，8（23）：101-102.
[16]	熊伟.探究睑板腺按摩联合聚乙二醇滴眼液治疗干眼症的临床效果[J].中国实用医药，2016，11（29）：181-182.